Al-Dawaa Medical Services Co
SAU:4163
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (15.4), the stock would be worth ﷼100.28 (16% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 13.3 | ﷼86.7 |
0%
|
| 3-Year Average | 15.4 | ﷼100.28 |
+16%
|
| 5-Year Average | 16.2 | ﷼105.52 |
+22%
|
| Industry Average | 22.9 | ﷼149.15 |
+72%
|
| Country Average | 19.3 | ﷼125.89 |
+45%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
﷼6.7B
|
/ |
Oct 2025
﷼501.4m
|
= |
|
|
﷼6.7B
|
/ |
Dec 2025
﷼506m
|
= |
|
|
﷼6.7B
|
/ |
Dec 2026
﷼519.6m
|
= |
|
|
﷼6.7B
|
/ |
Dec 2027
﷼545.5m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| SA |
|
Al-Dawaa Medical Services Co
SAU:4163
|
4.8B SAR | 13.3 | 13.2 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
65.1B ZAR | 13.8 | 20.1 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
30.7B ZAR | 15.7 | 24.8 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 5.1 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
38.5B BRL | 17.1 | 30.2 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
929.3B JPY | 14 | 21.8 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
911.6B JPY | 9.6 | 16.3 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 19 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29.9B CNY | 10.7 | 18.2 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 15.3 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
574.6B JPY | 11.4 | 12.8 |
Market Distribution
| Min | 1.6 |
| 30th Percentile | 15.3 |
| Median | 19.3 |
| 70th Percentile | 25.8 |
| Max | 2 801.3 |
Other Multiples
Al-Dawaa Medical Services Co
Glance View
In the bustling landscape of Saudi Arabia's healthcare sector, Al-Dawaa Medical Services Co. has carved out a significant niche, reliably serving the community with its comprehensive pharmacy and health-related services. Established in 1993, it has grown from a modest operation into a leading pharmacy chain across the Kingdom. Al-Dawaa operates under an integrated business model that combines retail pharmacy outlets with a diverse range of healthcare products and services, offering both essential medications and wellness goods. The company has adeptly aligned itself with global trends by embracing technology, enabling it to offer online consultations and an e-commerce platform for purchasing health products, thus broadening its reach and enhancing customer convenience. Revenue streams for Al-Dawaa are multifaceted, driven by the strategic placement of its extensive network of pharmacies in high-footfall areas and residential communities. The company generates income through the sale of prescription drugs, over-the-counter medications, health and beauty products, dietary supplements, and personal care items. Additionally, Al-Dawaa strengthens its profitability by partnering with a wide array of global pharmaceutical and consumer goods companies, ensuring a diverse and reliable supply chain. Furthermore, their loyalty programs and customer-centric services create a strong brand allegiance, enticing repeat business and solidifying their position as a trusted household name in healthcare in the region. By continuously adapting to consumer needs and adhering to high service standards, Al-Dawaa Medical Services Co. secures its role as a pivotal player in the Saudi healthcare market.